Skip to main content

Advertisement

Table 1 Proxy relative survival (RS), cancer site-standardized proxy RS and health expenditures (GLOBOCAN 2012) among countries with proxy RS ≥0.55

From: Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures

Rank Country a No. of new cases b Unadjusted proxy RS Site-standardized proxy RS (rank) Total health expenditure per capita (US$) c Public health expenditure per capita (US$) c
1 Australia 122,031 0.702 0.609 (2) 6543.5 4395.5
2 Iceland 1449 0.692 0.586 (5) 3856.8 3106.5
3 Norway 28,214 0.688 0.594 (3) 9360.8 7947.0
4 Switzerland 42,046 0.678 0.586 (6) 9195.7 5950.1
5 Republic of Korea 219,520 0.674 0.622 (1) 1714.9 941.9
6 USA 1,603,586 0.667 0.587 (4) 8789.8 4154.0
7 Israel 29,176 0.667 0.536 (24) 2514.6 1581.8
8 Finland 28,428 0.665 0.559 (16) 4254.8 3221.8
9 Puerto Rico 11,822 0.663 0.550 (19) n.a. n.a.
10 Sweden 50,481 0.659 0.521 (28) 6521.6 5501.1
11 Luxembourg 2476 0.654 0.579 (9) 7550.7 6301.6
12 Canada 182,182 0.651 0.579 (8) 5719.0 4059.4
13 New Zealand 21,337 0.648 0.539 (23) 4470.9 3702.1
14 Ireland 20,808 0.648 0.561 (15) 4079.5 2756.6
15 Germany 493,780 0.645 0.583 (7) 4753.9 3616.1
16 France 349,426 0.644 0.574 (11) 4698.9 3625.6
17 Belgium 65,345 0.638 0.564 (14) 4587.9 3563.5
18 Italy 354,456 0.635 0.552 (17) 3242.2 2442.7
19 Malta 1902 0.632 0.567 (13) 2216.6 1475.7
20 Denmark 36,119 0.631 0.544 (21) 6203.8 5320.3
21 Cyprus 3438 0.617 0.518 (29) 1964.8 901.1
22 The Netherlands 93,448 0.616 0.529 (26) 5456.5 4721.2
23 France, Martinique 1808 0.612 0.444 (41) n.a. n.a.
24 Spain 215,534 0.606 0.571 (12) 2651.4 1901.8
25 Portugal 49,174 0.598 0.542 (22) 1999.8 1280.5
26 United Kingdom 327,812 0.597 0.534 (25) 3648.7 3025.2
27 Austria 41,117 0.593 0.549 (20) 5239.5 3948.9
28 Czech Republic 57,627 0.586 0.551 (18) 1411.5 1185.9
29 Barbados 1144 0.585 0.429 (46) 1137.9 741.6
30 Slovenia 11,457 0.577 0.512 (32) 2068.5 1502.5
31 New Caledonia 886 0.573 0.470 (35) n.a. n.a.
32 Japan 703,863 0.568 0.577 (10) 4748.9 3927.1
33 France, La Reunion 1868 0.564 0.517 (30) n.a. n.a.
34 Singapore 15,693 0.562 0.529 (27) 2310.4 821.3
  1. Data sources: GLOBOCAN 2012 for the calculation of number of new cases, unadjusted proxy RS and cancer site-standardized proxy RS;1 The World Bank for health expenditures5
  2. a Countries with unadjusted proxy RS ≥0.55 were listed
  3. b Refer to the number of new cases for “all cancers excluding non-melanoma of skin” 1
  4. c n.a.: Total and public health expenditures were not available for these countries for the year 20125